Chylomicrons enhance endotoxin excretion in
暂无分享,去创建一个
H. Harris | K. Feingold | C. Grunfeld | T. Read | J. Rapp | M. C. Calhoun | P. Kane
[1] J. Hoofnagle,et al. Lymphokines and bile secretion in the rat. , 2008, Liver.
[2] H. Harris,et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. , 1993, The Journal of clinical investigation.
[3] K. Feingold,et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. , 1992, Journal of lipid research.
[4] P. Brandtzaeg,et al. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. , 1992, The Journal of clinical investigation.
[5] K. Emancipator,et al. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins , 1992, Infection and immunity.
[6] H. Harris,et al. Chylomicrons can inhibit endotoxin activity in vitro. , 1991, The Journal of surgical research.
[7] K. Feingold,et al. Tumor necrosis factor, cytokines, and the hyperlipidemia of infection , 1991, Trends in Endocrinology & Metabolism.
[8] H. Harris,et al. Detection of endotoxin in triglyceride-rich lipoproteins in vitro. , 1991, The Journal of laboratory and clinical medicine.
[9] J. Swaney,et al. High density lipoprotein subpopulations from galactosamine-treated rats and their transformation by lecithin:cholesterol acyltransferase. , 1991, Journal of lipid research.
[10] H. Harris,et al. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. , 1990, The Journal of clinical investigation.
[11] J. Cavaillon,et al. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide , 1990, Infection and immunity.
[12] A. Wendel,et al. Studies on the hepatotoxicity of galactosamine/endotoxin or galactosamine/TNF in the perfused mouse liver. , 1990, Biochemical pharmacology.
[13] M. Meza,et al. Colchicine prevents D-galactosamine-induced hepatitis. , 1989, Journal of hepatology.
[14] D. Morrison,et al. The physical-chemical characterization and biologic activity of serum released lipopolysaccharides. , 1988, Journal of immunology.
[15] J. Berliner,et al. Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form. , 1988, The Journal of clinical investigation.
[16] H. S. Warren,et al. Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum. , 1986, The Journal of infectious diseases.
[17] R. Munford,et al. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. , 1986, Science.
[18] P. Edwards,et al. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[19] B. Beutler,et al. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. , 1985, Journal of immunology.
[20] C. Galanos,et al. Alterations in rats in vivo of the chemical structure of lipopolysaccharide from Salmonella abortus equi. , 1985, European journal of biochemistry.
[21] R. Munford,et al. Effects of specific antibodies, hormones, and lipoproteins on bacterial lipopolysaccharides injected into the rat. , 1985, The Journal of infectious diseases.
[22] C. Galanos,et al. Excretion of radioactivity in faeces and urine of rats injected with 3H,14C-lipopolysaccharide. , 1985, British journal of experimental pathology.
[23] J. H. Shaw,et al. Effect of sepsis on VLDL kinetics: responses in basal state and during glucose infusion. , 1985, The American journal of physiology.
[24] C. Galanos,et al. Distribution and localization of endotoxin in the reticulo-endothelial system (RES) and in the main vessels of the rat during shock. , 1985, Pathology, research and practice.
[25] R. Havel,et al. Uptake and processing of remnants of chylomicrons and very low density lipoproteins by rat liver. , 1984, Journal of lipid research.
[26] C. Galanos,et al. The fate of lipopolysaccharide in rats: evidence for chemical alteration in the molecule. , 1984, Reviews of infectious diseases.
[27] J. Stuart,et al. An improved chromogenic substrate endotoxin assay for clinical use. , 1983, Journal of clinical pathology.
[28] P. Tso,et al. Intestinal lipoproteins in the rat with D-(+)-galactosamine hepatitis. , 1983, Journal of lipid research.
[29] J. Lipton,et al. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. , 1982, The Journal of clinical investigation.
[30] A. Cerami,et al. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Knook,et al. Clearance capacity of rat liver Kupffer, Endothelial, and parenchymal cells. , 1981, Gastroenterology.
[32] N. Kaplowitz,et al. The hepatocellular uptake and biliary excretion of endotoxin in the rat , 1981, Hepatology.
[33] E. Wisse,et al. Uptake by liver cells of endotoxin following its intravenous injection. , 1981, Laboratory investigation; a journal of technical methods and pathology.
[34] R. Ulevitch,et al. New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. , 1981, The Journal of clinical investigation.
[35] R. Ulevitch,et al. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. , 1979, The Journal of clinical investigation.
[36] R. Ulevitch,et al. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. , 1979, Journal of immunology.
[37] R. Ulevitch,et al. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. , 1978, The Journal of clinical investigation.
[38] R. Ulevitch. The preparation and characterization of a radioiodinated bacterial lipopolysaccharide. , 1978, Immunochemistry.
[39] G. Blackburn. Lipid metabolism in infection. , 1977, The American journal of clinical nutrition.
[40] E. Masoro. Fat metabolism in normal and abnormal states. , 1977, The American journal of clinical nutrition.
[41] S. Sabesin,et al. Lipoprotein and lecithin: cholesterol acyltransferase changes in galactosamine-induced rat liver injury , 1975, Science.
[42] E. Ribi,et al. PHYSICAL ASPECTS OF REVERSIBLE INACTIVATION OF ENDOTOXIN * , 1966, Annals of the New York Academy of Sciences.
[43] A. Braude,et al. Studies with Radioactive Endotoxin. II. Correlation of Physiologic Effects with Distribution of Radioactivity in Rabbits Injected with Lethal Doses of E. Coli Endotoxin Labelled with Radioactive Sodium Chromate , 1955 .
[44] O. Lüderitz,et al. Über die Extraktion von Bakterien mit Phenol/Wasser , 1952 .
[45] C. Galanos,et al. Metabolic fate of endotoxin in rat. , 1990, Advances in experimental medicine and biology.
[46] S. Sabesin,et al. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. , 1989, Journal of lipid research.
[47] E. Wisse,et al. Cultured Kupffer cells, isolated from human and rat liver biopsies, ingest endotoxin. , 1988, Journal of hepatology.
[48] E. Wisse,et al. Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. , 1988, Journal of hepatology.
[49] G. Ramadori,et al. Hepatocellular clearance function of bacterial lipopolysaccharides and free lipid A in mice with endotoxic shock. , 1984, The American journal of emergency medicine.
[50] D. Keppler,et al. Galactosamine induced liver injury. , 1972, Progress in liver diseases.
[51] D. Keppler,et al. Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis. , 1971, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.